Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

3.580 +0.040 (+1.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adma Biologics

< Previous 1 2 3 4 Next >
Why Shares of ADMA Biologics Are Climbing Thursday
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed. 
Via The Motley Fool
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Preview: ADMA Biologics's Earnings
Via Benzinga
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
Conference Call Scheduled for August 9, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Recap: ADMA Biologics Q1 Earnings
Via Benzinga
A Preview Of ADMA Biologics's Earnings
Via Benzinga
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Outlook For ADMA Biologics
Via Benzinga
Looking Into ADMA Biologics's Return On Capital Employed
Via Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Dow Down 150 Points; US Durable Goods Orders Drop In February
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.50% to 31,944.01 while the NASDAQ fell 0.52%... 
Via Benzinga
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday
With US futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
ADMA Biologics Inc (NASDAQ: ADMA) shares are moving higher in extended trading Thursday after the commercial biopharmaceutical company reported  
Via Benzinga
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
Conference Call Scheduled for March 23, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
7 A-Rated Penny Stocks Worth Betting On
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
Via InvestorPlace
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like... 
Via Benzinga
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.